Results 241 to 250 of about 34,653 (293)
Some of the next articles are maybe not open access.

Making Hybridomas

2005
Hybridomas are derived from the fusion of spleen and myeloma cells and produce monoclonal antibodies. Each hybridoma cell line produces an antibody with a unique specificity allowing the production of highly defined reagents that can be used in many branches of immunochemistry.
openaire   +2 more sources

Immunochemistry of Hybridomas

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
The attraction of monoclonal antibodies lies in the potential availability of an unlimited supply of material, homogeneity, reproducibility, and the feasibility of manipulation for specific purposes. Their use, however, is limited because of structural and physicochemical idiosyncrasies, occasionally restrictive factors influencing affinity and avidity,
openaire   +1 more source

Hybridoma Technology

2022
Hybridoma technology combines the unique qualities of antibody-producing B cells with immortalized myeloma cells, creating hybrid cells capable of endless proliferation while retaining the ability to produce specific antibodies. The process begins with the immunization of a host animal, typically a mouse, followed by the fusion of its spleen cells ...
openaire   +1 more source

Cryopreservation of Hybridomas

2003
Hybridomas are exposed to many threats, such as contamination with bacteria and fungi, loss of chromosomes coding for antibody production, overgrowth by nonsecreting mutants, and cell death resulting from overgrowth. Therefore, newly established hybridomas should be frozen and stored in liquid nitrogen at -196°C as soon as possible. Alternatively, they
openaire   +2 more sources

Cloning of Hybridomas

2003
Hybrid clones will appear within 2-3 wk after fusion (see Chapter 46). It is of utmost importance that a newly established hybridoma is cloned thoroughly to ensure that the cells growing in the tissue culture are of monoclonal origin and not a mixture of two or more hybridomas.
openaire   +2 more sources

Hybridoma stability.

Developments in biological standardization, 1995
Hybridoma stability issues include mutations, chromosome losses, and the potential effects of process variables on the yield, quality and homogeneity of the Monoclonal Antibody (MAb) product. MAb production by murine hybridomas is typically unstable in the early stages after fusion but repeated cloning normally produces stable clones.
F J, Castillo   +7 more
openaire   +1 more source

Hybridoma technology

La Ricerca in Clinica e in Laboratorio, 1984
openaire   +2 more sources

Lymphocyte hybridomas

Cancer Treatment Reviews, 1982
openaire   +2 more sources

Home - About - Disclaimer - Privacy